■ 英語タイトル：Global Female Neonatal Devices Market Size study & Forecast, by Type (Bone Densitometry, Breast Biopsy, Breast Imaging, Other) by Application (Female, Neonatal) and Regional Analysis, 2022-2029
	■ 発行会社/調査会社：Bizwit Research & Consulting ■ 商品コード：BZW23MR089 ■ 発行日：2023年3月6日 ■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東 ■ 産業分野：医療 ■ ページ数：約200 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後3営業日）

Global Female Neonatal Devices Market is valued approximately USD 434.40 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.90% over the forecast period 2022-2029. Female Neonatal Devices are essential tools used in gynecology and obstetrics procedures to assess foetal health during labor and delivery. The Female Neonatal Devices market is expanding because of factors such as rising breast imaging procedures and growing number of premature births.

Neonatal gadgets are frequently utilized in intensive care units, where complex machinery and monitoring devices are designed for the new-born babies. Its prevalence has progressively increased during the last few decades. According to the World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years. According to the U.S. Department of Health and Human Services, in 2022, it is estimated that there will be 287,850 new cases of female breast cancer and an estimated 43,250 people will die of this disease. Another important component driving space increase is premature births. According to the American Academy of Pediatrics, in 2019 Premature birth occurs in about 11 to 13 percent of pregnancies in the US. Almost 60 percent of twins, triplets, and other multiple deliveries result in preterm births. In addition, as per Statista, in 2020, some 10.1 percent of all births in the United States were preterm births. However, high cost associated with female neonatal devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Female Neonatal Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the increasing level of expenditure for healthcare infrastructure. According to Statista, revenue in the Medical Technology market is projected to reach USD 579.40 billion in 2023. In global comparison, most revenue will be generated in the United States USD 199.80 billion by 2023. Furthermore, Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising adoption of advanced healthcare, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

Koninklijke Philips N.V.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthcare GmbH
Medtronic
Abbott
F. Hoffmann-La Roche Ltd.
General Electric
FUJIFILM Holdings Corporation
SOMATEX Medical Technologies GmbH
Hologic, Inc.

Recent Developments in the Market:
 In July 2021, Abbott launched the world’s first medical device that can be implanted in the tiniest of babies weighing as little as 700 gm using a minimally invasive procedure to treat patent ductus arteriosus, or PDA. The Amplatzer Piccolo Occluder, a device smaller than a pea, offers premature infants and newborns who need corrective treatment, and who may be non-responsive to medicine and are at high risk to undergo corrective surgery.

Global Female Neonatal Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type
Bone Densitometry
Breast Biopsy
Breast Imaging
Other

by Application
Female
Neonatal

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World